BLOOD CANCERS
Clinical trials for BLOOD CANCERS explained in plain language.
Never miss a new study
Get alerted when new BLOOD CANCERS trials appear
Sign up with your email to follow new studies for BLOOD CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple therapy aims to wipe out lingering leukemia cells
Disease control Recruiting nowThis study tests a combination of three drugs (tagraxofusp, azacitidine, and venetoclax) in adults with acute myeloid leukemia (AML) who are in remission but still have tiny amounts of cancer cells that can't be seen under a microscope. The goal is to see if the treatment can saf…
Matched conditions: BLOOD CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New tool helps blood cancer patients choose treatments that fit their lives
Knowledge-focused Recruiting nowThis study tests a decision-support tool called PRIME for adults aged 60 and older with blood cancers like lymphoma, leukemia, or multiple myeloma. The tool helps patients clarify what matters most to them and shares that with their doctors. The goal is to see if using PRIME lead…
Matched conditions: BLOOD CANCERS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 08:14 UTC